The influence of sex hormone levels on tear production in postmenopausal Nigerian women

Absztrakt

Background: A stable tear film with normal flow is essential for preserving a clear cornea. When the tear film becomes insufficient to support the surface of the eye due to a lack of production of tears or a decrease in stability of tears, dry eye syndrome (DES) occurs. DES is a common disorder of the tear film. It affects a significant percentage of the population, especially women. The onset of dry eye is very common during menopause and may result from the loss of hormonal support.

Objective: The purpose of this study was to assess the effect of sex hormone on tear volume and stability in postmenopausal Nigerian women.

Method: This study was a cross sectional experimental study. Twenty postmenopausal women aged 50 to 55 years (mean age 52 ± 2.32) and twenty premenopausal women aged 45 to 52 years (mean age 50 ± 2.13) were selected by systematic random sampling. Schirmer’s tear test and the noninvasive tear break up time (NITBUT) test were performed on the women. Serum levels of estradiol, progesterone and testosterone were determined.

Results: The differences in mean tear volume, (t=14.74, p<0.0001) and tear stability, (t=11.28, p<0.04) between the postmenopausal and premenopausal women were statistically significant. Tear volume was positively correlated with testosterone (r=0.276, p > 0.05) and progesterone (r=0.227, p > 0.05) but negatively correlated with estradiol (r=0.141, p > 0.05) in the postmenopausal group, with no statistically significant associations.

Conclusion: Changes in hormone levels that occur in menopause affect tear volume and tear stability.

Keywords: Tears, menopause, volume, stability, hormones.

Résumé
Introduction : Une stable taie de larme avec flux normal est essentielle pour préservée une cornée claire. Quand la taie de larme devient insuffisante pour supporter la surface de l’œil dû au manque de production des larmes ou une baisse en stabilité des larmes, le syndrome de l’œil sec (DES) survient. DES est un désordre commun de la taie de larme. Il affecte un pourcentage significatif de la population, spécialement les femmes. L’occurrence de l’œil sec est très commune durant la ménopause et peut en résulter de la perte du support hormonal.

Objective : Le but de cette étude était de repartir l’effet du sexe hormone sur le volume et stabilité de larme dans les femmes nigérianes post-ménopausée.

Méthode : Cette étude était une étude expérimentale à cross section. Vingt femmes post-ménopausées âgées de 50 à 55 ans (âge moyen 52 2,32) et vingt femmes pré-ménopausées âgées de 45 à 52 ans (âge moyen 50 2,13) étaient choisies au hasard par échantillonnage systématique. Le Schirmer réactif de larme et la non-invasive rompure du temps (NITBUT) réactif de larme étaient effectués sur les femmes. Les niveaux de sérum de l’œstradiol, progestérone et testostérone étaient déterminés.

Résultats : Les différences en moyen de volume de larme, (t=11,28 p<0,04) entre les femmes post-ménopausées et préménopausées étaient statistiquement significatives. Le volume de larme était positivement corrélatif avec testostérone (r=0,276 p0,05) et progestérone (r=0,227 p0,05) mais négativement corrélatif avec l’œstradiol (r=0,141 p0,05) dans le groupe des post-ménopausées, sans avec associations statistiquement significatives.

Conclusion : Les changements dans les niveaux d’hormone qui se produisent dans la ménopause affectent le volume de larme et la stabilité de larme.

Mots clés: Larmes, ménopause, volume, stabilité, hormones.

Correspondence: Dr. J.A. Ebeigbe, Department of Optometry, Faculty of Life Sciences, University of Benin, Benin City, Nigeria. E-mail: jenniferebeigbe@yahoo.com.

pdf (angol)

Hivatkozások

Marcozzi G, Maria F, Del Biango G et al. Lacrimal gland peroxidase activity during the menstrual cycle. Current eye research. 2000; 20 :(3) 178-182.

Sullivan D. Tearful relationship? Sex, Sex hormone, the lacrimal and aqueous deficient dry eye. Ocul Surf. 2004; 2: 92 – 123.

Caffery B, Richter D, Simpson T, et al.: The Canadian dry eye epidemiology study. Adv Exp Med Boil. 1998; 438: 805 – 866.

Tatlipinar S, Gedik S, Irkee M, et al. Ocular ferning pattern during menstrual cycle in healthy women. Eur J Ophthalmol. 2001;11: (1)15-18.

Suzuki T, Schirra F, Richards S, et al. Estrogen and progesterone control of gene expression in the mouse meiboman gland. Invest. Ophthalmol. 2008; 49(5): 1797 -1808.

Ajayi A, Mathur R and Haluska P. Testosterone increases human platelet thromboxane A2 receptor density and aggregation response. Circulation.1995: 91 (11): 2742 – 2747.

Behl C, windmann M, Trapp and, Hobsboer F. 17 –beta estradiol protects neurons from oxidative and induced cell death invitro. Biochem. Biophys. Res. Commun. 1995; 216 (20): 473 – 482.

Schein OD, Tielsh JM, Munoz B, et al. Relation between signs and symptoms of dry eye in the elderly : a population-based perspective. Ophthalmology 1997; 104: 1395-1401.

Bron AJ. Non-Sjogren’s dry eye: pathogenesis diagnosis and animal models. In: Sullivan DA, editor. Lacrimal gland, tear film, and dry eye syndromes. New York: Plenum Press, 1994; 471-488.

Sator MO, Joura EA, Golasewski T, et al. Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol. Br J Obstet Gynaecol. 1998; 105: 100-102.

Gupta PD, Kaid Johar SR, Nagpal K and Vasavada AR. Sex hormone receptors in the human eye. Surv Ophthalmol. 2005: 50; 274-284.

Metka M, Enzelsberger H, Knogler W, et al. Ophthalmic complaints as a climacteric symptom. Maturitas. 1991; 14: 3-8.

Stulting RD, Mader TH and Waring GO. Diagnosis and management of tear film dysfunction. In: Leibowitz HM, Waring GO III, editor. Corneal disorders clinical diagnosis and management. 2nd ed. Philadelphia: W.B. Saunders, 1998; 482-500.

Erdem, U, Ozdegirmenci O, Sobaci E, et al. Dry eye in postmenopausal women using hormone replacement therapy. Maturitas. 2007;56(3):257-262.

Uncu G Avci R, Uncu Y, et al. The effect different hormone replacement therapy regimen on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol. 2006; 22 (9) 501 – 505.

Mathers W, Dalev T and Verdick R. Video imaging of the meibomian gland. Arch ophthalmol.1994; 112:448 -449.

Okon A, Jurowski P and Gos R. The influence of hormonal replacement therapy on the amount and stability of the tear film among pre and postmenopausal women. Klin Oezna. 2001; 103 (4-6):177-181.

Pan D, Liu W, Yang X and Cao F. Inhibitory effect of progesterone in inflammatory factors after experimental traumatic brain injury. Biomed Environ Sc. 2004; 20(5): 432 -438.

Schaumberg D, Sullivan D, Dana R and Buring J. Prevalence of dry eye syndrome Amongst US women. Am J Ophthalmol. 2003; 136: 318 – 326.

Yolton D, Yolton R, Lopez R, et al. The effect of gender and birth control pills use on spontaneous blink rate. J Am Optom Assoc. 1994;65(11):763-770.

Schaumberg D, Buring J, Sullivan D and Daria M. Hormone replacement therapy and dry eye syndrome. J Am Med Assoc. 2001; 286: 2114-2119.

Sullivan DA, Sullivan BD, Evan JE et al. Androgen deficiency, meibomian gland dysfunction and evaporative dry eye. Ann NY Acad Sci. 2002; 966: 211 – 222.

Vavilis D, Agorastos T, Vakiani M et al. The effect of transdermal estradiol on the conjunctival in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 1997;72(1):93-96.

Tomlinson A, Pearce EI, Simmons PA and Blades K. Effect of oral contraceptive on tear physiology. Ophthalmic Physiol Opt. 2001; 21: (1) 9-16.

Mather WD, Stovall D, Lance JA, et al. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea. 1998; 17: 353-358.

Kramer P, Lubkin V, Potter W, et al. Cyclic changes in conjunctival smears from menstruating females. Ophthalmology. 1990; 97: 303-307.

Serrander AM and Peek KE. Changes in contact lens comfort related to the menstrual cycle and menopause. J Am Optom Assoc. 1993; 64: 162-166.

Krenzer KL, Dana MR, Ullman MD et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab. 2000 ; 85(12): 4874-4882.

Seal DV. The effect of aging and disease on tear constituents. Trans Ophthalmol Soc UK. 1985; 104: 355-361.

Auw-Haedrich C and Feltgen N. Estrogen receptor expression in meibomian glands and its correlation with age and dry-eye parameters. Graefes Arch Clin Exp Ophthalmol.2003; 241: 705-709.

Sullivan DA, Bélanger A, Cermak JM. et al. Are women with Sjögren’s syndrome androgen deficient? J Rheumatol. 2003; 30(11):2413-2419.

Wickham LA, Gao J, Toda I, et al. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand. 2001; 78: 146-153.

Smith JA, Vitale S, Reed GF et al. Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol. 2004; 122: 151-156.